JP2022031585A - Three-dimensional cell structure having valve function, manufacturing method thereof, and support body - Google Patents
Three-dimensional cell structure having valve function, manufacturing method thereof, and support body Download PDFInfo
- Publication number
- JP2022031585A JP2022031585A JP2020135429A JP2020135429A JP2022031585A JP 2022031585 A JP2022031585 A JP 2022031585A JP 2020135429 A JP2020135429 A JP 2020135429A JP 2020135429 A JP2020135429 A JP 2020135429A JP 2022031585 A JP2022031585 A JP 2022031585A
- Authority
- JP
- Japan
- Prior art keywords
- cell structure
- dimensional cell
- valve function
- manufacturing
- valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 26
- 210000004027 cell Anatomy 0.000 claims abstract description 104
- 238000003825 pressing Methods 0.000 claims abstract 6
- 239000012530 fluid Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000004745 nonwoven fabric Substances 0.000 claims description 4
- 239000000560 biocompatible material Substances 0.000 claims 1
- 210000005056 cell body Anatomy 0.000 claims 1
- 238000007599 discharging Methods 0.000 claims 1
- 239000003146 anticoagulant agent Substances 0.000 abstract description 7
- 229940127219 anticoagulant drug Drugs 0.000 abstract description 7
- 210000003709 heart valve Anatomy 0.000 abstract description 7
- 210000005260 human cell Anatomy 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 description 21
- 239000001963 growth medium Substances 0.000 description 6
- 210000000591 tricuspid valve Anatomy 0.000 description 5
- 230000004956 cell adhesive effect Effects 0.000 description 3
- 239000007779 soft material Substances 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 241000282412 Homo Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Images
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Prostheses (AREA)
Abstract
Description
本発明は、弁機能を有する立体細胞構造体、その作製方法及び支持体に関するものである。 The present invention relates to a three-dimensional cell structure having a valve function, a method for producing the same, and a support thereof.
現在主流となっている人工心臓弁は2種類の材料で作られたものがある。ウシ、ブタなどの生体の心臓弁を材料とする「生体弁」と、金属を材料とする「機械弁」の2種類である。
「生体弁」は血液の凝固が起こりにくいため、坑凝固剤を服用する必要はないが、耐用年数が10~20年と短く、若年者への移植後、再度置き換え手術が必要になる可能性がある。
「機械弁」は血液の凝固が起きやすいため、生涯の坑凝固剤を服用する必要がある。坑血液凝固剤は外傷時に止血しにくい、ほかの疾病にかかりやすくなるなどの副作用が指摘されている。
また、どちらも形状は固定的であるので体の成長とともに移植した弁が成長することはなく、乳幼児などは成長に応じて再手術が必要となる。
ヒトの細胞から心臓弁を形成することができれば上記課題を解決することができる。
Some of the artificial heart valves that are currently mainstream are made of two types of materials. There are two types, a "biological valve" made of a heart valve of a living body such as a cow or a pig, and a "mechanical valve" made of a metal.
Since blood coagulation is unlikely to occur in "biological valves," it is not necessary to take anticoagulants, but the service life is as short as 10 to 20 years, and replacement surgery may be required again after transplantation to young people. There is.
"Mechanical valves" are prone to blood coagulation, so it is necessary to take a lifelong anticoagulant. It has been pointed out that anticoagulants have side effects such as difficulty in stopping bleeding at the time of trauma and susceptibility to other diseases.
In addition, since the shape of both is fixed, the transplanted valve does not grow as the body grows, and infants and the like need to undergo reoperation according to their growth.
If a heart valve can be formed from human cells, the above problem can be solved.
細胞だけで管状細胞構造体を作製する手法が特許文献1(特許第6439223号)にて示されている。これによれば、細胞だけで作製された管状細胞構造体を得ることができる。これは単純な管状形状の細胞構造体を作製する手法であって、弁機能を有する立体細胞構造体形状を示すものではない。 Patent Document 1 (Patent No. 6439223) shows a method for producing a tubular cell structure using only cells. According to this, it is possible to obtain a tubular cell structure made only of cells. This is a method for producing a simple tubular cell structure, and does not indicate the shape of a three-dimensional cell structure having a valve function.
この様に現在の使用されている人工心臓弁には2つの課題がある。坑血液凝固剤の服用、及び耐用年数 である。
本発明は、細胞を用いて弁機能を有する立体細胞構造体を作製することで、この課題を解決する手法を提供することを目的とする。
As described above, the artificial heart valve currently used has two problems. Taking anticoagulant and useful life.
An object of the present invention is to provide a method for solving this problem by producing a three-dimensional cell structure having a valve function using cells.
上記課題を解決するために弁機能を有する立体細胞構造体の代表的な構成は、細胞のみもしくは主として細胞で構成された立体細胞構造体であり、立体細胞構造体の少なくとも一部は有軟性を備え、血液等の流体の流路を遮る弁機能を備えていることを特徴とする。
弁機能を有する立体細胞構造体を作製するためには、管状細胞構造体を培養液内で培養時に、立体細胞構造体の特定部に任意の培地の流れを付与することによって、弁形状を作製していく。これを開閉培養と呼ぶ。
開閉培養を行うことで、立体細胞構造体の弁部位が開閉動作を行い、弁機能に必要な形状に自己成型していくとともに、弁機能のために必要な強度を得ていく。
In order to solve the above problems, a typical configuration of a three-dimensional cell structure having a valve function is a three-dimensional cell structure composed only of cells or mainly composed of cells, and at least a part of the three-dimensional cell structure is flexible. It is characterized by having a valve function of blocking the flow path of a fluid such as blood.
In order to prepare a three-dimensional cell structure having a valve function, a valve shape is prepared by imparting a flow of an arbitrary medium to a specific part of the three-dimensional cell structure when the tubular cell structure is cultured in a culture medium. I will do it. This is called open / closed culture.
By performing open / close culture, the valve site of the three-dimensional cell structure opens and closes, self-molding into the shape required for the valve function, and obtaining the strength required for the valve function.
本発明によれば、細胞だけで弁機能を有する立体細胞構造体を作製することが可能になり、長い耐用性を持ち、坑血液凝固剤の服用が不要で、体の成長とともに成長する弁を提供できることが可能となる。 According to the present invention, it is possible to produce a three-dimensional cell structure having a valve function only with cells, a valve having a long durability, no need to take an anticoagulant, and a valve that grows as the body grows. It will be possible to provide.
弁機能を有する立体細胞構造体の作成方法を図を用いて説明する。 A method for creating a three-dimensional cell structure having a valve function will be described with reference to the drawings.
まず、細胞だけもしくは主として細胞を用いて作成された管状立体細胞構造体100を作製する。これは特許第6439223に示される手法などを用いて作製する。図1に示されるように、管状立体細胞構造体100は細胞が接着できる材質で作製された支持体110によって構成されている。支持体110は例えば不織布などの柔軟性に富む材料でもよいし、板状の材料でもよい。図1-bに示されるように細胞部分(開閉培養前)101と支持体110は融合している。この段階では弁機能は有していない。
First, a tubular three-
図2は立体細胞構造体が弁形状に作製された後の断面図である。a:開時は 弁機能を持つ立体細胞構造体(開示)102の弁部位の先端部同士が離れており、流路150が出現している。b:閉時は弁機能をもつ立体細胞構造体(閉時)103同士が接して流路150が消滅し、弁機能を生じている。 FIG. 2 is a cross-sectional view after the three-dimensional cell structure is formed into a valve shape. a: At the time of opening, the tips of the valve sites of the three-dimensional cell structure (disclosure) 102 having a valve function are separated from each other, and the flow path 150 appears. b: When closed, the three-dimensional cell structures having a valve function (when closed) 103 are in contact with each other and the flow path 150 disappears, resulting in a valve function.
図3は開閉培養のシステム全体図である。
a:弁 開時 は コントローラー500にあらかじめプログラミングされた速度及び角度でステッピングモーター400を回転させ、ピストン310をシリンダ210に押し込んでいくと同時に培養液が吐出され、弁機能を持つ立体細胞構造体(開示)102が押し広げられて、弁が開放状態となる。
b:弁 閉時は逆の動きとなり、培養液が吸引されるとともに、弁機能をもつ立体細胞構造体(閉時)103が閉じられて、弁が閉鎖状態となる。
上記 a, b を繰り返すことで、立体細胞構造体100が弁機能に即した形状に整形されていくとともに、弁機能に必要な強度を得て弁機能を有する立体細胞構造体105となる。
FIG. 3 is an overall view of the open / closed culture system.
a: When the valve is opened, the
b: When the valve is closed, the movement is reversed, the culture medium is sucked, and the three-dimensional cell structure (when closed) 103 having a valve function is closed, and the valve is closed.
By repeating the above steps a and b, the three-
哺乳類の心臓弁の一形態が三尖弁と呼ばれる、弁葉が3つある形状である。この三尖弁に類似した形状を作製するために、管状細胞構造体の内腔内に動きを制限する支持体を挿入して培養する。図4は硬性支持体を内腔内に固定した写真である。
図5は図3に示される開閉培養中の a :弁開時、b:弁閉時 の写真である。
支持体120の材料は、当然であるが細胞毒性を有しないものに限定される。更に、生体適合性を持つ材料が望ましい。また、細胞が接着できる材質でもよいし、接着できない材質でもよい。細胞が接着する場合は不織布などの空間の多い材料が望ましいが、板材料の表面に凹凸を設けて接着しやすくすることでもよい。また、平滑な面でも細胞が接着できるような処理をしていればよい。支持体120に細胞非接着性の材料を用いた場合は、支持体120を立体細胞構造体105と分離し、立体細胞構造体105を心臓に移植することができる。支持体120に細胞接着性の材料を用いた場合は、支持体120は形状保持の機能を保持したまま心臓に移植することができる。
A form of mammalian heart valve is called the tricuspid valve, which has three leaflets. In order to create a shape similar to this tricuspid valve, a support that restricts movement is inserted into the lumen of the tubular cell structure and cultured. FIG. 4 is a photograph in which a rigid support is fixed in a lumen.
FIG. 5 is a photograph of a: when the valve is opened and b: when the valve is closed during the open / closed culture shown in FIG.
The material of the support 120 is, of course, limited to those that are not cytotoxic. Further, a material having biocompatibility is desirable. Further, it may be a material to which cells can adhere or a material to which cells cannot adhere. When cells adhere, a material with a large space such as a non-woven fabric is desirable, but it is also possible to provide irregularities on the surface of the plate material to facilitate adhesion. In addition, it suffices if the treatment is performed so that the cells can adhere even on a smooth surface. When a non-cellular material is used for the support 120, the support 120 can be separated from the three-dimensional cell structure 105 and the three-dimensional cell structure 105 can be transplanted into the heart. When a cell-adhesive material is used for the support 120, the support 120 can be transplanted into the heart while retaining the function of shape retention.
図6aは軟性の材料で作製された軟性支持体を管状細胞構造体の内腔内に設置した際のイメージ図である。軟性支持体130は下方は支持体110などに固定され、上方は何らかの保持部分に固定されることで概ね直線形状を保ったまま保持される。軟性支持体130は管状細胞構造体100と接触して培養されており、細胞接着性がある材料の場合は培養が進むにつれ細胞と融合接着していく。
軟性支持体130は例えば三尖弁を作製する場合は支持体は円周上3か所に設置される。支持体の上端及び下端は容器、土台などに固定される。上記にある手法で開閉繰り返すことで、立体細胞構造体100が弁機能に即した形状に整形されていくとともに、弁機能に必要な強度を得て弁機能を有する立体細胞構造体105となる。
支持体130に細胞非接着性の材料を用いた場合は、支持体130を立体細胞構造体105と分離し、立体細胞構造体105を心臓に移植することができる。支持体130に細胞接着性の材料を用いた場合は、支持体130は強度保持の機能を保持したまま心臓に移植することができる。また、支持体130は生体に吸収される材質でもよい。
bは一例の写真である。軟性支持体130が三方に設置され、管状細胞構造体100と融合している。
FIG. 6a is an image diagram of a soft support made of a soft material placed in the lumen of a tubular cell structure. The lower part of the flexible support 130 is fixed to the support 110 or the like, and the upper part is fixed to some kind of holding portion so that the flexible support 130 is held while maintaining a substantially linear shape. The flexible support 130 is cultured in contact with the
For the flexible support 130, for example, when making a tricuspid valve, the supports are installed at three places on the circumference. The upper and lower ends of the support are fixed to a container, a base, or the like. By repeating opening and closing by the above-mentioned method, the three-
When a non-cellular material is used for the support 130, the support 130 can be separated from the three-dimensional cell structure 105 and the three-dimensional cell structure 105 can be transplanted into the heart. When a cell-adhesive material is used for the support 130, the support 130 can be transplanted into the heart while retaining the function of maintaining strength. Further, the support 130 may be made of a material that is absorbed by a living body.
b is an example photograph. Flexible supports 130 are placed on three sides and fused with
図7は開閉培養を行い硬性支持体120を除去した後の弁機能を有する立体細胞構造体の全体写真である。三尖弁に類似の形状となり、弁機能を有している。 FIG. 7 is an overall photograph of a three-dimensional cell structure having a valve function after opening and closing culture and removing the rigid support 120. It has a shape similar to that of a tricuspid valve and has a valve function.
図8は図7の細胞部分を5ミクロン厚にスライスして撮像したHE染色画像である。右頂部が他の弁葉と接する部分であるが、きれいに滑らかな曲線になっていることがわかる。また、内部まで細胞の核が存在していることがわかる。 FIG. 8 is an HE-stained image obtained by slicing the cell portion of FIG. 7 to a thickness of 5 microns. It can be seen that the right apex is the part in contact with the other leaflets, but the curve is clean and smooth. In addition, it can be seen that the nucleus of the cell exists inside.
本発明により、細胞だけで弁機能を有する立体細胞構造体を作製することができる。本発明は例えばヒトへの心臓弁移植に使われる。この場合の弁機能を有する立体細胞構造体はヒト細胞のみで作製されるため異種間から生じる炎症リスクをなくし、金属などを使わないことから血栓が生じることなく血液抗凝固剤を不要とする。また、患者自身の細胞を用いて作成すれば、免疫拒絶のリスクも無くすことができる。更に、乳幼児などへの移植は身体の成長とともに弁が大型化すると考えられるため、再手術の必要もなくなる。心臓以外にも、下肢などの弁機能を持つ血管などにも利用することができる。 INDUSTRIAL APPLICABILITY According to the present invention, a three-dimensional cell structure having a valve function can be produced only by cells. The present invention is used, for example, for heart valve transplantation in humans. In this case, the three-dimensional cell structure having a valve function is made only of human cells, so that there is no risk of inflammation caused by different species, and since no metal or the like is used, no blood clots occur and no blood anticoagulant is required. In addition, the risk of immune rejection can be eliminated if the cells are prepared using the patient's own cells. Furthermore, transplantation to infants and the like is thought to cause the valve to become larger as the body grows, eliminating the need for reoperation. In addition to the heart, it can also be used for blood vessels with valve functions such as lower limbs.
100 管状立体細胞構造体の一例の写真(直管形状で弁形状は有しない)。
101 管状立体細胞構造体の断面概略図。
102 弁機能をもつ立体細胞構造体が開放時の断面概略図。
103 弁機能をもつ立体細胞構造体が閉鎖時の断面概略図
105 弁機能をもつ立体細胞構造体の一例の写真
108 弁機能をもつ立体細胞構造体の染色画像の一例
109 弁機能をもつ立体細胞構造体の染色画像拡大の一例
110 立体細胞構造体に接続された支持体。
120 細胞構造体内部に設置された硬い材質で作製された支持体。
130 細胞構造体内部に設置された柔軟性をもつ材質で作製された支持体
200 培養液を保持するシリンダー。
300 ピストンが、培養液を吸引した状態。
310 ピストンが、培養液を吐出した状態。
400 ピストンを稼働させるステッピングモーター
500 ステッピングモーターを制御するコントローラー
100 Photograph of an example of a tubular three-dimensional cell structure (straight tube shape, no valve shape).
101 A schematic cross-sectional view of a tubular three-dimensional cell structure.
102 A schematic cross-sectional view of a three-dimensional cell structure having a valve function when it is open.
103 Schematic cross-section of a three-dimensional cell structure with a valve function when it is closed 105 Photograph of an example of a three-dimensional cell structure with a valve function 108 Example of a stained image of a three-dimensional cell structure with a valve function 109 Three-dimensional cell with a valve function An example of magnifying a stained image of a structure 110 A support connected to a three-dimensional cell structure.
120 A support made of a hard material placed inside a cell structure.
130 Support 200 made of flexible material placed inside the cell structure Cylinder holding the culture medium.
300 The piston sucks the culture solution.
310 The piston discharges the culture solution.
400 Stepping motor that operates the piston 500 Controller that controls the stepping motor
Claims (20)
中央に貫通孔が形成された管状の立体細胞構造体を用意する工程と、
前記立体細胞構造体の端部に圧力を印加し、当該端部に、当該端部を開閉可能な弁機能を付与する工程と、
を有する製造方法。 It is a method for manufacturing a three-dimensional cell structure.
The process of preparing a tubular three-dimensional cell structure with a through hole formed in the center,
A step of applying pressure to the end of the three-dimensional cell structure to impart a valve function capable of opening and closing the end to the end.
Manufacturing method having.
中央に貫通孔が形成された管状の立体細胞構造体の一方の端部を支持する支持手段と、
前記立体細胞構造体の貫通孔内に流体を印加し、前記立体細胞構造体の他方の端部に、当該他方の端部を開閉可能な弁機能を形成する形成手段と、
を有する製造装置。 A device for manufacturing a three-dimensional cell structure having a valve function.
A supporting means for supporting one end of a tubular three-dimensional cell structure having a through hole in the center,
A forming means for applying a fluid into the through hole of the three-dimensional cell structure to form a valve function at the other end of the three-dimensional cell structure so that the other end can be opened and closed.
Manufacturing equipment with.
前記形成手段は、前記シリンダーの往復動に応答して前記貫通孔内に印加する圧力を変化させる、請求項9または10に記載の製造装置。 The forming means includes a cylinder capable of reciprocating movement and a drive unit for driving the cylinder.
The manufacturing apparatus according to claim 9 or 10, wherein the forming means changes the pressure applied into the through hole in response to the reciprocating motion of the cylinder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020135429A JP6881798B1 (en) | 2020-08-08 | 2020-08-08 | A three-dimensional cell structure having a valve function, a method for producing the same, and a support |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020135429A JP6881798B1 (en) | 2020-08-08 | 2020-08-08 | A three-dimensional cell structure having a valve function, a method for producing the same, and a support |
Publications (2)
Publication Number | Publication Date |
---|---|
JP6881798B1 JP6881798B1 (en) | 2021-06-02 |
JP2022031585A true JP2022031585A (en) | 2022-02-21 |
Family
ID=76083880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020135429A Active JP6881798B1 (en) | 2020-08-08 | 2020-08-08 | A three-dimensional cell structure having a valve function, a method for producing the same, and a support |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6881798B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002500004A (en) * | 1997-12-31 | 2002-01-08 | アドバンスド ティシュー サイエンシズ,インコーポレーテッド | Apparatus and method for simulating in vivo conditions during inoculation and culture of a three-dimensional tissue construct |
JP2008532653A (en) * | 2005-03-11 | 2008-08-21 | ウエイク・フオレスト・ユニバーシテイ・ヘルス・サイエンシズ | Manufacture of heart valves with engineered tissue |
-
2020
- 2020-08-08 JP JP2020135429A patent/JP6881798B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002500004A (en) * | 1997-12-31 | 2002-01-08 | アドバンスド ティシュー サイエンシズ,インコーポレーテッド | Apparatus and method for simulating in vivo conditions during inoculation and culture of a three-dimensional tissue construct |
JP2008532653A (en) * | 2005-03-11 | 2008-08-21 | ウエイク・フオレスト・ユニバーシテイ・ヘルス・サイエンシズ | Manufacture of heart valves with engineered tissue |
Non-Patent Citations (1)
Title |
---|
CIRCULATION, vol. 114, JPN7020003303, 2006, pages 152 - 158, ISSN: 0004369946 * |
Also Published As
Publication number | Publication date |
---|---|
JP6881798B1 (en) | 2021-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9642940B2 (en) | 3-dimensional parylene scaffold cage | |
KR101628275B1 (en) | Mesh enclosed tissue constructs | |
US10783803B2 (en) | Methods and devices for modeling the eye | |
JP4282905B2 (en) | Corneal onlay | |
US9999500B2 (en) | Anti thrombogenic heart valve and medical implements | |
EP1625832B1 (en) | Method of removing cell | |
KR20050105480A (en) | Method and device for the formation of biological cell material | |
US11773362B2 (en) | Modular bioreactor, compliance chamber for a bioreactor, and cell seeding apparatus | |
CN105326581B (en) | A kind of method for preparing polyethylene glycol protein fiber composite heart valve prosthesis | |
JP2009125068A (en) | Multilayered culturing apparatus | |
US20140038221A1 (en) | Bioengineered human trabecular meshwork for biological applications | |
WO2006105444A2 (en) | Bioreactor for development of blood vessels | |
JP5731728B2 (en) | Sealed cell culture vessel and cell culture method using the same | |
RU2476187C2 (en) | Medical implant and method of its manufacturing | |
JP6881798B1 (en) | A three-dimensional cell structure having a valve function, a method for producing the same, and a support | |
KR20210137842A (en) | Membrane for forming biomaterial structure comprising artificial blood vessel, artificial biomaterial structure comprising the membrane and method for manufacturing the same | |
JP2007037764A (en) | Prosthetic valve | |
Kobayashi et al. | An artificial blood vessel with an endothelial-cell monolayer | |
JP5837530B2 (en) | Sealed cell culture vessel and cell culture method using the same | |
WO2005113743A2 (en) | Device for carrying out a liquid/air culture of epithelium | |
Kurniawan | Perfusion 3D Bioprinting with Gelatin and Hydrogel for Vascular Tissue Engineering | |
CN108379663B (en) | Device and method for trapping and enriching cells in porous regular body scaffold material | |
JP2006238987A (en) | Substrate for forming connective tissue sheet (biosheet) and method for producing biosheet | |
KR101574585B1 (en) | Mobile bio-scaffold controlled by magnetic field | |
Helms et al. | A fibrin-based bioengineered tissue construct including a multi-scale vascular network |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200812 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200812 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20200815 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20200828 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201110 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20201111 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201210 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210118 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210413 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210423 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6881798 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |